These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 11458404)
1. Glycoprotein IIb/IIIa inhibitors: more different than alike? Stone GW Catheter Cardiovasc Interv; 2001 Jul; 53(3):304-7. PubMed ID: 11458404 [No Abstract] [Full Text] [Related]
2. Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment. Tcheng JE Am J Cardiol; 1999 May; 83(9A):7E-11E. PubMed ID: 10357575 [No Abstract] [Full Text] [Related]
4. Advances in antiplatelet therapy for acute coronary syndromes. Clem JR; Falls S S D J Med; 1998 Jul; 51(7):233-4. PubMed ID: 9676157 [No Abstract] [Full Text] [Related]
5. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions. Gambhir DS; Mukhopadhyay S Indian Heart J; 2000; 52(5):524-32. PubMed ID: 11256774 [No Abstract] [Full Text] [Related]
6. The role of glycoprotein IIb/IIIa inhibition in the management of acute coronary syndromes. Koller CF Heart Lung; 2001; 30(5):321-9; quiz 330-1. PubMed ID: 11604974 [TBL] [Abstract][Full Text] [Related]
10. Platelet glycoprotein IIb/IIIa inhibition as adjunctive therapy during primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. Young JJ J Invasive Cardiol; 2005 Jun; 17(6):300-1. PubMed ID: 16003003 [No Abstract] [Full Text] [Related]
11. A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes. Tcheng JE Am Heart J; 1999 Oct; 138(4 Pt 2):261-2. PubMed ID: 10502231 [No Abstract] [Full Text] [Related]
13. The TARGET trial: hit or miss? Moliterno DJ; Topol EJ Eur Heart J; 2002 Jun; 23(11):835-7. PubMed ID: 12042001 [No Abstract] [Full Text] [Related]
14. GP IIb/IIIa inhibitors: an evidence-based approach to their use. Med Manag Netw; 1999 Mar; 7(3):5-9. PubMed ID: 10346546 [No Abstract] [Full Text] [Related]
15. Management of acute ischaemic coronary syndromes beyond aspirin therapy: role of glycoprotein IIb/IIIa antagonists. Gambhir DS Indian Heart J; 1998; 50(2):151-4. PubMed ID: 9622980 [No Abstract] [Full Text] [Related]
16. Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: risk stratification and therapeutic intervention. Januzzi JL; Cannon CP; Theroux P; Boden WE Am Heart J; 2003 Nov; 146(5):764-74. PubMed ID: 14597924 [TBL] [Abstract][Full Text] [Related]
17. IIb/IIIa platelet inhibitors in the management of coronary artery disease. Talley JD J Ark Med Soc; 1996 Oct; 93(5):237-9. PubMed ID: 8908943 [No Abstract] [Full Text] [Related]
18. Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy. Wu KK; Willerson JT Circulation; 2001 May; 103(21):2528-30. PubMed ID: 11382717 [No Abstract] [Full Text] [Related]